Actively Recruiting
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Led by Samsung Medical Center · Updated on 2025-06-22
2000
Participants Needed
1
Research Sites
343 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum and cell-free DNA will be collected and analyzed.
CONDITIONS
Official Title
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pathologically diagnosed Hodgkin and non-Hodgkin lymphomas
- 20 years or older
- Patients requiring systemic chemotherapy with curative intent
- Written informed consent given
You will not qualify if you...
- Diagnosis of myeloid malignancy
- Diagnosis of multiple myeloma
- Patients who do not require systemic chemotherapy with curative intent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Medical Center
Seoul, South Korea, 06351
Actively Recruiting
Research Team
S
Seok Jin Kim, MD., PhD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here